As of October 2024, Sinopharm Group has a market cap of $2.92B. This makes Sinopharm Group the world's 4052th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.55B | 0.73% |
2023 | $3.52B | 3.07% |
2022 | $3.42B | 16.98% |
2021 | $2.92B | -9.88% |
2020 | $3.24B | -33.85% |
2019 | $4.90B | -13.53% |
2018 | $5.66B | -2.66% |
2017 | $5.82B | 5.79% |
2016 | $5.50B | 2.73% |
2015 | $5.35B | 13.30% |
2014 | $4.73B | 23.37% |
2013 | $3.83B | -8.25% |
2012 | $4.18B | 29.96% |
2011 | $3.21B | -31.14% |
2010 | $4.67B | -1.63% |
2009 | $4.74B | - |